These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 394087)

  • 21. Proceedings: Changes of pharmacokinetic parameters of new antiinflammatory drugs influenced by drug interaction.
    Zathurecký L; Szelepcsényiová A; Bruncková E; Masaryková V; Hajnovic F
    Acta Pharm Suec; 1974 Dec; 11(6):654-5. PubMed ID: 1173537
    [No Abstract]   [Full Text] [Related]  

  • 22. Diphenylhydantoin half-life in man and its inhibition by phenylbutazone: the role of genetic factors.
    Andreasen PB; Froland A; Skovsted L; Andersen SA; Hauge M
    Acta Med Scand; 1973 Jun; 193(6):561-4. PubMed ID: 4738705
    [No Abstract]   [Full Text] [Related]  

  • 23. Comparison of plasma levels of antipyrine, tolbutamide, and warfarin after oral and intravenous administration.
    Andreasen PB; Vesell ES
    Clin Pharmacol Ther; 1974 Dec; 16(6):1059-65. PubMed ID: 4611464
    [No Abstract]   [Full Text] [Related]  

  • 24. Phenylbutazone: factors influencing plasma concentrations.
    Davies DS
    J Int Med Res; 1977; 5 Suppl 2():15-9. PubMed ID: 913869
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Short-term tolbutamide effect on patients with liver cirrhosis.
    Hirayama C; Kawasaki H; Arimura K; Amagase H
    Acta Hepatogastroenterol (Stuttg); 1974 Feb; 21(1):34-40. PubMed ID: 4450960
    [No Abstract]   [Full Text] [Related]  

  • 26. Studies on synthetic sweetening agents. XV. Metabolism of sodium cyclamate. Influences of phenylbutaone, phenobarbital, and tolbutamide on metabolism of sodium cyclamate in rabbits.
    Ichibagase H; Kojima S; Inoue K; Suenaga A
    Chem Pharm Bull (Tokyo); 1972 Jan; 20(1):175-80. PubMed ID: 5014543
    [No Abstract]   [Full Text] [Related]  

  • 27. Interaction of pargyline with tolbutamide in rabbits.
    Satyanarayana S; Krishna DM; Krishnaiah YS; Visweswaram D
    Indian J Physiol Pharmacol; 1995 Jan; 39(1):71-3. PubMed ID: 7705875
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of alphamethyldopa on the half-lives of antipyrine, tolbutamide and D-glucaric acid excretion in man.
    Gachályi B; Tornyossy M; Vas A; Káldor A
    Int J Clin Pharmacol Ther Toxicol; 1980 Mar; 18(3):133-5. PubMed ID: 6103880
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Warfarin-phenylbutazone interaction in man: a long term multiple dose study.
    Schary WL; Lewis RJ; Rowland M
    Res Commun Chem Pathol Pharmacol; 1975 Apr; 10(4):663-72. PubMed ID: 1153844
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Implications of enzyme induction in drug toxicity studies.
    Welch RM; Harrison YE; Burns JJ
    Toxicol Appl Pharmacol; 1967 Mar; 10(2):340-51. PubMed ID: 4962253
    [No Abstract]   [Full Text] [Related]  

  • 31. Warfarin. Stereochemical aspects of its metabolism and the interaction with phenylbutazone.
    Lewis RJ; Trager WF; Chan KK; Breckenridge A; Orme M; Roland M; Schary W
    J Clin Invest; 1974 Jun; 53(6):1607-17. PubMed ID: 4830225
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Drug interactions in the horse: effects of chloramphenicol, quinidine, and oxyphenbutazone on phenylbutazone metabolism.
    Tobin T; Blake JW; Valentine R
    Am J Vet Res; 1977 Jan; 38(1):123-7. PubMed ID: 835859
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of phenylbutazone on the metabolic disposition of warfarin in the dog.
    Bachmann KA; Burkman AM; Feller DR
    Res Commun Chem Pathol Pharmacol; 1976 Aug; 14(4):747-50. PubMed ID: 959670
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A study of the possible interaction of indoprofen with hypoglycemic sulfonylureas in diabetic patients.
    Pedrazzi F; Bommartini F; Freddo J; Emanueli A
    Eur J Rheumatol Inflamm; 1981; 4(1):26-31. PubMed ID: 7042358
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Drug interactions in the horse: effect of furosemide on plasma and urinary levels of phenylbutazone.
    Roberts BL; Blake JW; Tobin T
    Res Commun Chem Pathol Pharmacol; 1976 Oct; 15(2):257-65. PubMed ID: 981785
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Interaction between naproxen and tolbutamide on metabolism in diabetics].
    Sachse G; Willms B; Becker R
    Arzneimittelforschung; 1979; 29(5):835-6. PubMed ID: 582983
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of low estrogen combination oral contraceptive on metabolism of aspirin and phenylbutazone.
    Gupta KC; Joshi JV; Hazari K; Pohujani SM; Satoskar RS
    Int J Clin Pharmacol Ther Toxicol; 1982 Nov; 20(11):511-3. PubMed ID: 7174153
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of lead exposure on plasma phenylbutazone levels in rats.
    Basu N; Kulsreshtha T
    Indian J Physiol Pharmacol; 1994 Jan; 38(1):61-2. PubMed ID: 8132249
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of tuberculostatic agents on the response of serum growth hormone and immunoreactive insulin to intravenous tolbutamide, and on the half-life of tolbutamide.
    Syvälahti E; Pihlajamäki K; Iisalo E
    Int J Clin Pharmacol Biopharm; 1976 Mar; 13(2):83-9. PubMed ID: 1254383
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of phenylbutazone on the metabolism of C14-cortisol.
    Downie WW; Reid G; Browning MC
    Ann Rheum Dis; 1973 Jan; 32(1):89-90. PubMed ID: 4685890
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.